Oral TKI or IV ADC for HER2 NSCLC? The first oral medication for this disease, Zongertinib, is now approved, joining established IV therapies like Trastuzumab deruxtecan. Our experts discuss how to choose ▶️ https://www.facebook.com/events/566988496426095 #Oncology #CME | Medscape

Looking to improve outcomes for patients with advanced COPD/emphysema? This free Medscape CME provides practical guidance on identifying and supporting candidates for endobronchial valve treatment. | Pulmonx | Facebook

Musculoskeletal Ultrasound Trainng & CME Courses l August 12-16, 2019. Click www.gcus.com, or call 727.363.4500 to learn more and register. #msk #musculoskeletal #orthopedics #rheumotology #radiology #sportsmedicine #physician | Gulfcoast Ultrasound Institute, Inc.